Cargando…

CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities

Elevated circulating concentrations of low-density lipoprotein cholesterol (LDL-C) have been conclusively demonstrated in epidemiological and intervention studies to be causally associated with the development of atherosclerotic cardiovascular disease. Enormous advances in LDL-C reduction have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Harry E., Rizzo, Manfredi, Fras, Zlatko, Jug, Borut, Banach, Maciej, Penson, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707018/ https://www.ncbi.nlm.nih.gov/pubmed/34940615 http://dx.doi.org/10.3390/metabo11120857

Ejemplares similares

Challenges and Opportunities on Lipid Metabolism Disorders Diagnosis and Therapy: Novel Insights and Future Perspective
por: Fras, Zlatko, et al.
Publicado: (2021)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

Prognostic Impact of Nonobstructive Coronary Artery Disease Detected by Coronary Computed Tomographic Angiography
por: Košuta, Daniel, et al.
Publicado: (2021)

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
por: Banach, Maciej, et al.
Publicado: (2022)

Vascular Function in Patients After Myocardial Infarction: The Importance of Physical Activity
por: Tršan, Jure, et al.
Publicado: (2021)

Effects of Cardiac Rehabilitation and Diet Counselling on Adherence to the Mediterranean Lifestyle in Patients after Myocardial Infarction
por: Novaković, Marko, et al.
Publicado: (2022)

The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
por: Penson, Peter E., et al.
Publicado: (2020)

The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis
por: Dehnavi, Sajad, et al.
Publicado: (2019)

Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
por: Banach, Maciej, et al.
Publicado: (2020)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort
por: Grbić, Emin, et al.
Publicado: (2020)

Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
por: Poropat Flerin, Tadeja, et al.
Publicado: (2022)

CRISPR/Cascade 9-Mediated Genome Editing-Challenges and Opportunities
por: Roy, Bhaskar, et al.
Publicado: (2018)

CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement
por: Zegeye, Workie Anley, et al.
Publicado: (2022)

Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)

Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
por: Banach, Maciej, et al.
Publicado: (2021)

Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment
por: Vekic, Jelena, et al.
Publicado: (2022)

The effects of statins on blood pressure: current knowledge and future perspectives
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Effects of statins on the incidence and outcomes of acute kidney injury in critically ill patients: a systematic review and meta-analysis
por: Vahedian-Azimi, Amir, et al.
Publicado: (2023)

Drucebo effect – the challenge we should all definitely face!
por: Banach, Maciej, et al.
Publicado: (2021)

Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
por: Penson, Peter E., et al.
Publicado: (2021)

Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies
por: Banach, Maciej, et al.
Publicado: (2021)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Use of CRISPR systems in plant genome editing: toward new opportunities in agriculture
por: Ricroch, Agnès, et al.
Publicado: (2017)

New European Society of Cardiology Guidelines on diabetes; prediabetes, and cardiovascular diseases - a truly strong base for the major paradigm shift in clinical practice?
por: Fras, Zlatko
Publicado: (2019)

Increased cardiovascular risk associated with hyperlipoproteinemia (a) and the challenges of current and future therapeutic possibilities
por: Fras, Zlatko
Publicado: (2020)

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
por: Cicero, Arrigo F.G., et al.
Publicado: (2017)

Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
por: Lohia, Aayushi, et al.
Publicado: (2022)

Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013)

Prediction of designer-recombinases for DNA editing with generative deep learning
por: Schmitt, Lukas Theo, et al.
Publicado: (2022)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Dietary salt intake and atherosclerosis: an area not fully explored
por: Banach, Maciej, et al.
Publicado: (2023)

Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level
por: Fendler, Wojciech, et al.
Publicado: (2014)

COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
por: Surma, Stanisław, et al.
Publicado: (2021)

LDL-C: lower is better for longer—even at low risk
por: Penson, Peter E., et al.
Publicado: (2020)

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
por: Kazemian, Pardis, et al.
Publicado: (2022)

Domain-specific introduction to machine learning terminology, pitfalls and opportunities in CRISPR-based gene editing
por: O’Brien, Aidan R, et al.
Publicado: (2020)

Moderate-dose atorvastatin improves arterial endothelial function in patients with angina pectoris and normal coronary angiogram: a pilot study
por: Kabaklić, Amela, et al.
Publicado: (2017)

RNA Silencing in the Management of Dyslipidemias
por: Henney, Neil C., et al.
Publicado: (2021)

Complications of Diabetes 2017
por: Papatheodorou, Konstantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tib4rg44c5p9a2anoh7smp0537